Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3709464010 | Dehydrocholic acid- and pancreatin- and simethicone-containing product in oral dose form | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3709465011 | Dehydrocholic acid- and pancreatin- and simeticone-containing product in oral dose form | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3709466012 | Product containing dehydrocholic acid and pancreatin and simeticone in oral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing dehydrocholic acid and pancreatin and simeticone in oral dose form (medicinal product form) | Is a | Product containing dehydrocholic acid and pancreatin and simeticone | true | Inferred relationship | Existential restriction modifier | ||
| Product containing dehydrocholic acid and pancreatin and simeticone in oral dose form (medicinal product form) | Has active ingredient | Simeticone | true | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing dehydrocholic acid and pancreatin and simeticone in oral dose form (medicinal product form) | Has manufactured dose form | Oral dose form | true | Inferred relationship | Existential restriction modifier | ||
| Product containing dehydrocholic acid and pancreatin and simeticone in oral dose form (medicinal product form) | Is a | Product containing simeticone in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing dehydrocholic acid and pancreatin and simeticone in oral dose form (medicinal product form) | Has active ingredient | Pancreatin | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing dehydrocholic acid and pancreatin and simeticone in oral dose form (medicinal product form) | Has active ingredient | Dehydrocholic acid | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing dehydrocholic acid and pancreatin and simeticone in oral dose form (medicinal product form) | Is a | Product containing dehydrocholic acid and dimeticone and pancreatin in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing dehydrocholic acid and pancreatin and simeticone in oral dose form (medicinal product form) | Plays role | Digestant therapeutic role | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely dehydrocholic acid 180 milligram and pancreatin 300 milligram and simeticone 40 milligram/1 each conventional release oral tablet | Is a | False | Product containing dehydrocholic acid and pancreatin and simeticone in oral dose form (medicinal product form) | Inferred relationship | Existential restriction modifier | |
| Product containing only dehydrocholic acid and pancreatin and simeticone in oral dose form (medicinal product form) | Is a | True | Product containing dehydrocholic acid and pancreatin and simeticone in oral dose form (medicinal product form) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR